Clinical trial

A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)

NCT06627322

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-11-21

PhaseNA

Study timeline

Study start (actual)2024-11-21Date precision: day

Registry last updated2025-04-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

Dual-combination therapyDRUG

Triple-combination therapyDRUG

Dexcom G7, PastaDEVICE

Sponsors & collaborators

Kyu Chang Wonlead sponsor

Boryung Pharmaceutical Co., Ltdcollaborator

Dong-A ST Co., Ltd.collaborator

HK inno.N Corporationcollaborator

Daewoong Pharmaceutical Co. LTD.collaborator

Chong Kun Dang Pharmaceutical Corp.collaborator

Celltrioncollaborator

Kakao Healthcare Corp.collaborator

Handok Inc.collaborator

Mapped research locations

SeoulSouth Korea1 DaeguSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06627322 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.